Benefits
Exercise capacity and physical performance
Clinical trials show improvements in exercise capacity, time to exhaustion, and grip strength with Kaempferia parviflora supplementation in healthy and older adults. Effects build over weeks of consistent use combined with training.
Erectile function improvement
Clinical trials in men with mild erectile dysfunction show modest improvements in erectile function with Kaempferia parviflora. Laboratory work points to phosphodiesterase-5 inhibition as one proposed mechanism. The human evidence is a single small open-label pilot with no placebo group, so the size of any real effect is uncertain.
Fat oxidation and energy metabolism
Methoxyflavones activate AMPK and support fat oxidation, particularly during exercise. Clinical trials show modest improvements in body composition over weeks of supplementation combined with physical activity.
Grip strength in older adults
Trials in older adults show improvements in grip strength — a marker of overall muscle function and predictor of longevity — with Kaempferia parviflora supplementation over months of use.
PDE5 inhibition mechanism
In laboratory assays methoxyflavones inhibit phosphodiesterase-5, which raises cGMP and can promote vasodilation. This is a proposed mechanism from test-tube data, not a demonstrated clinical effect, and it should not be read as equivalent to a prescription PDE-5 medication.
Cardiovascular effects not demonstrated in humans
No human trial on this page measured a cardiovascular outcome such as blood pressure, endothelial function, or lipids. Any cardiovascular benefit is speculative and rests on mechanism alone.
AMPK activation for metabolic effects
Methoxyflavones activate AMPK, an energy-sensing enzyme, in cell and animal studies. This is a plausible mechanism for the metabolic and exercise signals, but it has not been shown to reproduce the clinical effects of any prescription drug.
Generally well-tolerated
Clinical trials show good tolerability with side effects no more frequent than placebo. Decades of traditional Thai use support a reasonable safety profile, though long-term high-dose safety data is still emerging.
Mechanism of action
PDE-5 inhibition (laboratory mechanism)
In laboratory assays polymethoxyflavones inhibit phosphodiesterase-5. This is the proposed basis for the sexual-function signal, but in people it has only been tested in one small uncontrolled study. Because the enzyme is also the target of prescription ED drugs, combining the two could in theory add up, so caution is warranted.
Cellular energy metabolism enhancement
Increased cellular energy metabolism contributes to improved physical fitness performance and muscular endurance. Mechanism distinct from caffeine-style stimulant pathways.
Brown adipose tissue activation and thermogenesis
BAT activation evidence supports a thermogenic mechanism distinct from caffeine-based thermogenics. Methodological quality of the underlying trial was limited (Jadad 1) — interesting mechanism awaiting better-designed human trials.
Polymethoxyflavone bioactivity (5,7-DMF)
Methoxylation distinguishes from typical flavonoids — enhances oral bioavailability, membrane permeability, and diverse pharmacological activities. 12 different methoxyflavones identified. 5,7-DMF is the primary bioavailability marker.
Anti-inflammatory NF-κB pathway
NF-κB pathway suppression contributes anti-inflammatory effects — relevant to the osteoarthritis indication in the literature.
Testosterone biosynthesis support
Mouse testis-derived cell evidence — preclinical testosterone biosynthesis support. Mechanistic basis for the men's-health positioning, though human testosterone outcomes have not been demonstrated.
Adipocyte hypertrophy suppression
Adipocyte hypertrophy suppression supports the anti-obesity research signal. Preclinical mechanism.
Clinical trials
Clinical evidence on Black Ginger (Kaempferia parviflora / Krachaidum / Thai Ginseng) for the indications and outcomes described.
13 men
Stein RA et al. 2018 (J Integr Med 16(4):249-254). Open-label, uncontrolled pilot with no placebo group: 13 healthy men aged 50 to 68 with self-reported mild ED took 100 mg/day of a K. parviflora ethanol extract (KaempMax, from the study sponsor Life Extension) for 30 days. IIEF scores improved and about 62 percent reported better erections, but without a control group the true effect size is unknown.
Clinical evidence on Black Ginger (Kaempferia parviflora / Krachaidum / Thai Ginseng) for the indications and outcomes described.
Clinical population described in trial publication.
Saokaew S et al. 2017 (J Evid Based Complementary Altern Med 22(3):413-428). Systematic review of 7 small clinical trials. The authors concluded the evidence is positive but inconclusive because the studies were small: increased hand-grip strength rested on 2 studies and enhanced sexual response on 1. No serious adverse events were reported.
Clinical evidence on Black Ginger (Kaempferia parviflora / Krachaidum / Thai Ginseng) for the indications and outcomes described.
Clinical population described in trial publication.
Promthep K et al. 2015 (Med Sci Monit Basic Res 21:100-8). Randomized, double-blind, placebo-controlled trial in 60 soccer players given 180 mg/day K. parviflora extract or placebo for 12 weeks. Hand-grip strength improved, but sprint speed, back-and-leg strength, flexibility, and cardiorespiratory fitness did not differ from placebo.